Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated 4 minutes ago

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 18, Status: Authorised

11 minutes ago

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Date of authorisation: 20/08/2026, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Date of authorisation...

Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,palonosetron, Date of authorisation...

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 22, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 20, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin...

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 7, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation...

Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Date of authorisation: 15/07/2026, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Date of...

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 20, Status: Authorised

about 19 hours ago

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation...

Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation: 24/03/2026, Revision: 1, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation...